China’s Drug Volume-Based Procurement Policy Shows Some Cracks
About 7 years ago, China initiated a volume-based procurement (VBP) policy to award drug companies with large sales opportunities but at significantly lower prices – oftentimes, VBP winners have drug price discounts of 50% to 90%. There have been 10 rounds of VBP... Read More